In silico analysis with the Mutational Significance in Cancer framework discovered 35 genes that were mutated at rates significantly above the background mutation rate, suggesting a pathological role for these implicated genes.
The estimated mutation rate suggests that approximately 2 to 6 new mutations will occur each month in a virus assuming the overall uniform mutation rate.
Similar to the effect on survival, NAC and GSH reduced the increase in the mutation rate, suggesting that the mutations are at least the result of oxidative damage to DNA.
In contrast to mutS, complementation with wild-type mutL or mutY had no effect on mutant frequency and mutation rate, suggesting a marginal impact, if any, of mutations to these genes in PAHM4.
Also, the collapse in hybrid fitness took place within a similar number of generations, regardless of the mutation rate, suggesting that a single mutation, or a very small number of mutations, is responsible for the collapse, rather than a slow build-up of different alleles in the two populations.
Studies focused on oral or tongue squamous cell carcinoma show possible population differences in prevalence for EGFR mutation rates, suggesting ethnic differences may exist [ 24– 37].
Reassuringly, i n vitro drug sensitivity patterns and mutation rates suggest that overall P. falciparum drug resistance was stable in Kenya from 2006 through 2009.
We show that orthologous microRNAs display highly similar temporal profiles regardless of their mutation rates, suggesting that the timely expression of microRNA genes can be more constrained than their sequence.
Tentative dating analyses using an uncorrelated log-normal relaxed clock and two published estimates of COI mutation rates suggest that diversification within the group occurred throughout the Pliocene and mid-Miocene (~2.4 11.5 mya).
Estimates that are based on known mutation rates suggest that every cell division creates some form of genetic variation, which may or may not have an effect on cellular function [ 2, 3].
